Stomach cancer (credit: canva)
Stomach cancer is a type of cancer that develops in the lining of the stomach. Also, known as Gastric cancer, it affects the elderly more than the adult. According to the American Cancer Society, about 6 of every 10 people diagnosed with stomach cancer each year are 65 or older. Also, the lifetime risk of developing stomach cancer is higher in men (about 1 in 101) than in women (about 1 in 155).
A health expert, speaking to a leading media house, emphasized five common symptoms of stomach cancer that should not be ignored:
1. Unexplained weight loss: Losing weight without trying or experiencing an unexplained drop in appetite, which may signal cancer progression.
2. Pain in the upper part of the abdomen: Persistent or occasional pain in the stomach area, often after eating, can become more severe as the condition progresses.
3. Frequent vomiting after meals: Nausea, sometimes accompanied by vomiting, may occur especially after meals and is linked to cancer blocking or irritating the stomach.
4. Vomiting blood, which may appear coffee-colored: This can indicate bleeding in the stomach, often caused by ulcers or tumors, and requires immediate medical attention.
5. Black, tarry stools: This occurs when blood from the stomach is digested and passed through the intestines, signaling potential internal bleeding
There are also other concerning signs that should not be overlooked such as jaundice, unexplained weight loss, early onset of diabetes, dark stools, and loss of appetite. Health experts strongly advise seeking immediate medical attention if you notice any of these symptoms. If you or a loved one experience these signs, it's crucial to visit a physician for a thorough evaluation to rule out serious underlying health conditions.
Oncologist Dr Pankaj Kumar Pande, Director–Surgical Oncology, Max Super Specialty Hospital, Shalimar Bagh, Delhi explained that this form of cancer spreads through three main pathways: Direct spread, lymphatic spread, and bloodstream.
1. Direct Spread: In its early stages, stomach cancer can invade nearby tissues and grow into the deeper layers of the stomach or spread to surrounding organs such as the oesophagus, liver, pancreas, or intestines.
2. Lymphatic Spread: Cancer cells can travel through the lymphatic system. The most common areas affected are the regional lymph nodes near the stomach, particularly those around the liver and diaphragm.
3. Bloodstream: "Cancer cells can enter the bloodstream and travel to distant parts of the body," which is a common route for stomach cancer to metastasize to distant organs.
He further explained that cancerous cells spread from the original tumour to other parts of the body through a process called Metastasis. The most common sites for the spread are the liver, lymph nodes, peritoneum, lungs, bones, and ovaries.
Credit: AI
The U.S. Centers for Disease Control and Prevention's (CDC) revised webpage on autism and vaccines has reignited debate over how health agencies should communicate scientific evidence.
Republican Senator Bill Cassidy slammed the agency's messaging while continuing to defend the overwhelming scientific evidence that vaccines do not cause autism.
The controversy was sparked on changes made to the CDC's autism webpage, which now states that the claim "vaccines do not cause autism" is "not an evidence-based claim" as studies have not ruled out every possible link between infant vaccines and autism.
The page also says the U.S. Department of Health and Human Services (HHS) is continuing to investigate the causes of autism.
The revised language represents a shift from the CDC's longstanding public messaging, which for years stated that extensive scientific research had found no causal relationship between vaccines and autism.
The changes have drawn criticism from scientists, physicians, and lawmakers who fear they could weaken public confidence in routine childhood immunization.
Sen. Bill Cassidy, a Louisiana Republican, physician, and chairman of the Senate Health, Education, Labor and Pensions Committee, recently said discussions with CDC Director nominee Dr. Erica Schwartz and HHS officials led to what he described as a "good faith" revision of the webpage.
"As a sign of good faith, HHS modified the CDC's autism and vaccines webpage. There is more to do to repair the damage that has been done to the U.S. public health response, but this is a start," Cassidy said.
Cassidy had previously questioned whether future CDC leadership would protect scientific integrity and resist political pressure on vaccine policy during Schwartz's Senate confirmation hearing.
While Cassidy ultimately announced his support for Schwartz's nomination, he has continued to stress that the agency should responsibly communicate established scientific evidence regarding vaccines.
Also read: Legionnaires' Disease Claims 5th Life In New York City: Health Officials
Despite the debate surrounding the CDC webpage, the broader scientific consensus has not changed.
Large studies conducted over several decades in multiple countries have consistently found no evidence that routine childhood vaccines cause autism.
Major medical organizations continue to support vaccination as one of the safest and most effective public health interventions.
Health experts have also warned that ambiguous or conflicting public health messaging could further affect vaccine confidence at a time when the United States is experiencing its highest number of measles cases in more than three decades, largely driven by declining childhood vaccination rates.
The controversy highlights the growing tension between political oversight and scientific communication within U.S. public health agencies.
For public health experts, the concern extends beyond a single webpage. They argue that how government agencies present scientific evidence can directly influence vaccine confidence, healthcare decisions, and efforts to prevent outbreaks of vaccine-preventable diseases.
Credit: AI
Artificial intelligence has steadily been becoming a bigger part of the healthcare sector. One of the biggest examples is ChatGPT.
Open AI recently begun rolling out Health in ChatGPT to eligible users in the United States, allowing people to securely connect medical records, Apple Health data, and other supported health sources directly to ChatGPT.
The feature aims to help users in understanding their lab reports better, document their medical history, prepare for doctor visits, and gauge complex medical information.
While it promises convenience and personalised health insights, it has also sparked concerns about privacy, data security, and how much trust people should place in AI for healthcare decisions.
It is currently available on the web and iOS for eligible Free, Go, Plus, and Pro users in the US, with the rollout happening gradually.
Once connected, users can ask questions such as:
Instead of uploading reports every time, ChatGPT can use connected health information, with the user’s permission, to provide more personalized explanations.
Also read: AIIMS Doctor Issues Warning After Patient Follows ChatGPT Advice, Suffers Internal Bleeding
According to the company, “Health is designed to support; not replace, medical care and is not intended for final diagnosis or treatment. For urgent symptoms or emergencies, seek immediate professional help.”
The company also states, “Conversations in Health are not used to train our foundation models.”
Users can disconnect connected accounts whenever they choose. OpenAI says synced data from disconnected sources is deleted from its systems within 30 days, although information already included in conversation history remains unless users delete those chats.
Medical records often contain technical terminology that patients struggle to interpret.
AI can translate complicated reports into simpler language that laymen can understand.
Patients can review previous reports, organise symptoms, and prepare questions before appointments, making doctor visits more productive.
People often have information spread across hospital portals, physical files, wearable devices, and fitness apps.
ChatGPT can combine these sources to identify patterns over time, like changes in sleep, physical activity, or important bio markers.
Rather than searching through multiple reports manually, users can quickly compare test results or check long-term changes with simple prompts.
Also read: Man Falls Ill After Seeking ChatGPT Advice on Cutting Salt
Despite the advantages, experts caution against relying too heavily on AI for healthcare.
Although OpenAI has introduced additional security measures, users are still sharing extremely sensitive personal health information with an AI platform.
Some AI privacy experts argue that any cloud-based storage of medical information is risky.
ChatGPT can explain information but may misunderstand context, overlook rare conditions, or generate inaccurate answers.
OpenAI clearly states that the feature must not replace professional medical advice, diagnosis, or treatment.
The launch comes amid renewed scrutiny over AI-generated medical advice.
A recently filed lawsuit alleges that a user delayed seeking emergency treatment after relying on ChatGPT’s health guidance.
While the allegations are still part of ongoing legal proceedings, the case has intensified discussions about the limitations of AI in healthcare.
If your goal is to better understand your lab reports, organise medical information, or prepare for doctor consultations, ChatGPT Health could become a useful health assistant.
However, if you are expecting AI to diagnose illnesses, decide treatments, or replace healthcare professionals, experts say that would be a mistake.
Healthcare decisions often depend on physical examinations, medical history, imaging, and clinical judgment, areas where AI cannot replace qualified doctors.
Credit: AI
The human brain may begin undergoing important immune changes much earlier than previously thought. A recent study found that these changes could help explain why the risk of dementia increases with age.
Researchers found that the hippocampus, the brain region responsible for learning and memory, experiences a major shift in its immune cells during the 40s and 50s.
The findings suggest that this change could lead to chronic inflammation associated with Alzheimer's disease and other forms of dementia in the future .
The study, conducted by scientists from the University of California San Diego, the New York Genome Center, and the University of California Irvine, analysed postmortem hippocampal tissue from 40 neurologically healthy adults aged between 20 and 95 years.
Researchers examined more than 1.2 million brain cells, discovering that around midlife, the brain's immune environment changes dramatically.
One of the biggest findings involved microglia, the brain's resident immune cells. While these cells normally protect the brain by clearing debris, fighting infections, and supporting neurons, researchers observed that they gradually shift into a more inflammatory state during middle age.
This altered immune environment resembles patterns commonly seen in neurodegenerative diseases like dementia.
Scientists have long known that aging is the strongest risk factor for dementia. However, exactly how normal aging causes diseases like Alzheimer's has remained vague.
The new findings suggest that the process may begin decades before symptoms like memory loss appear.
Instead of viewing aging as a slow, continuous process, the study indicates that the brain may pass through a distinct biological transition during midlife.
Once this immune environment changes, it may make the brain more vulnerable to inflammation and cognitive decline.
Richard J. Hodes, MD, Director of the National Institute on Aging (NIA), said, "Aging is the single largest risk factor for dementia, but our understanding of how it drives disease is still incomplete. This previously hidden microglial shift, now uncovered by innovations in technology and thinking, may be an important clue to help us complete the puzzle."
The researchers also believe these immune changes may not simply be a consequence of aging but could actively influence how the brain ages.
Also read: Can One Partner's Dementia Raise the Other's Risk? New Study Suggests An Interesting Link
Although the findings do not mean that everyone in their 40s or 50s will develop dementia, they provide researchers with a potential window for clinical intervention.
If scientists can identify or modify these immune changes before significant brain damage occurs, future therapies may be able to delay or even prevent neurodegenerative diseases.
Experts continue to recommend:
These lifestyle measures are already known to reduce several risk factors associated with dementia, and the new findings suggest they may be particularly important during the brain's midlife transition.
© 2024 Bennett, Coleman & Company Limited